Dr Julio Ribeiro is the Co-Founder and CEO of Inventia Life Science, a deeptech, biotechnology company. Inventia build instruments for the 3D printing of biomaterials (literal living human cells) to print 3D structures or models of tumors with an ultimate aim to accelerate the drug discovery process and speed up medical research.
The impact Julio and Inventia are looking to have is life-changing. To date, the pharmaceuticals industry has spent billions of dollars in research. According to Julio, 90% of drug trials fail. Inventia’s technology reduces the pipeline of unsuccessful drugs, speeding up the process of getting those that do work onto the market.
Inventia have to date raised $35million with the likes of Blackbird, Skipp Capital, Main Sequence and angels as investors. The top 10 pharmaceutical companies globally already utilise the technology, with labs all across the world and a global waitlist eager to use the technology. The current funds and next few years will see Inventia exploring the market and scaling up, increasing their production facilities, and expanding their sales force in US and Europe and team globally.
Quickfire Round Book: Carl Yeung - Memories, Dreams and ReflectionsPodcast: The EconomistNews Source: YouTube, French 24 ChannelTech CEO: Jamsetji TataProductivity Tool: Confluence, JiraApp: WhatsApp, YouTubeTV Show: Life is a movie - doesn’t watch TV or moviesTed Talk Topic: What we can do to improve medical research with the right balance between regulations and safety.
Inventia Life Science are on the lookout for talent in the fields of biology, software engineering and always welcome interns. Head to https://inventia.life/ for more information.

<div>Dr Julio Ribeiro is the Co-Founder and CEO of Inventia Life Science, a deeptech, biotechnology company. Inventia build instruments for the 3D printing of biomaterials (literal living human cells) to print 3D structures or models of tumors with an ultimate aim to accelerate the drug discovery process and speed up medical research.</div><div><br></div><div>The impact Julio and Inventia are looking to have is life-changing. To date, the pharmaceuticals industry has spent billions of dollars in research. According to Julio, 90% of drug trials fail. Inventia’s technology reduces the pipeline of unsuccessful drugs, speeding up the process of getting those that do work onto the market.</div><div><br></div><div>Inventia have to date raised $35million with the likes of Blackbird, Skipp Capital, Main Sequence and angels as investors. The top 10 pharmaceutical companies globally already utilise the technology, with labs all across the world and a global waitlist eager to use the technology. The current funds and next few years will see Inventia exploring the market and scaling up, increasing their production facilities, and expanding their sales force in US and Europe and team globally.</div><div><br></div><div>Quickfire Round </div><div>Book: Carl Yeung - Memories, Dreams and Reflections</div><div>Podcast: The Economist</div><div>News Source: YouTube, French 24 Channel</div><div>Tech CEO: Jamsetji Tata</div><div>Productivity Tool: Confluence, Jira</div><div>App: WhatsApp, YouTube</div><div>TV Show: Life is a movie - doesn’t watch TV or movies</div><div>Ted Talk Topic: What we can do to improve medical research with the right balance between regulations and safety.</div><div><br></div><div>Inventia Life Science are on the lookout for talent in the fields of biology, software engineering and always welcome interns. Head to <a href="https://inventia.life/" target="_blank">https://inventia.life/</a> for more information.</div>

There is a lot of activity in the Australian startup ecosystem. Ideas, talent, and money are all flowing into this sector at an unprecedented rate. 

This weekly podcast brings in-depth interviews with the best people making the biggest difference.

It's brought to you by Ian Gardiner and Phaedon Stough, technology entrepreneurs helping to grow the startup sector in Australia and New Zealand. Ian and Phaedon co-founded Innovation Bay with a clear mission to help technology entrepreneurs succeed.

A weekly deep dive into Australia's tech and startup ecosystem. Brought to you by Innovation Bay

Open the Pod Bay Doors

The Australian and New Zealand startup ecosystem is burgeoning, exciting and filled with some of the most fascinating minds on the planet, all driven by a passion to make a positive and lasting impact. Open The Pod Bay Doors invites some of the brightest minds in the industry for deep conversations and awe-inspiring insights from their captivating journeys. Lend us your ears to gain some fresh knowledge and broaden your insights. Brought to you weekly by Innovation Bay. 

<p>The Australian and New Zealand startup ecosystem is burgeoning, exciting and filled with some of the most fascinating minds on the planet, all driven by a passion to make a positive and lasting impact. Open The Pod Bay Doors invites some of the brightest minds in the industry for deep conversations and awe-inspiring insights from their captivating journeys. Lend us your ears to gain some fresh knowledge and broaden your insights. Brought to you weekly by Innovation Bay. </p>

Dr Julio Ribeiro is the Co-Founder and CEO of Inventia Life Science, a deeptech, biotechnology company. Inventia build instruments for...

Advertisement